Key points are not available for this paper at this time.
Glucagon is a pancreatic hormone of 29 amino acids that regulates carbohydrate metabolism and glicentin is an intestinal peptide of 69 amino acids that contains the sequence of glucagon flanked by peptide extensions at the amino and carboxy termini. The glucagon gene encodes a precursor containing glucagon and two additional, structurally related, glucagon-like peptides separated by an intervening peptide. These peptides are encoded in separate exons. To determine whether the pancreatic and intestinal forms of glucagon arise by alternative RNA and/or protein processing, we used antisera to synthetic glucagon-like peptides and exon-specific, complementary oligonucleotides for analyses of proteins and mRNAs in pancreatic and intestinal extracts. Preproglucagon mRNAs are identical, but different and highly specific peptides are liberated in the two tissues. Immunocytochemistry shows colocalization of glucagon and the two glucagon-like peptides in identical cells. We conclude that diversification of preproglucagon gene expression occurs at the level of cell-specific post-translational processing.
Building similarity graph...
Analyzing shared references across papers
Loading...
Svetlana Mojsov
G. Heinrich
Ira B. Wilson
Journal of Biological Chemistry
Harvard University
Howard Hughes Medical Institute
Massachusetts General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Mojsov et al. (Mon,) studied this question.
www.synapsesocial.com/papers/6a086ccb9a6c4ba6e6109eb5 — DOI: https://doi.org/10.1016/s0021-9258(18)67324-7
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: